Profund Advisors’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$235K Buy
27,750
+7,941
+40% +$75.7K 0.01% 928
2025
Q4
$240K Sell
19,809
-5,369
-21% -$65.2K 0.01% 1042
2025
Q3
$294K Buy
25,178
+2,272
+10% +$27.2K 0.01% 745
2025
Q2
$213K Buy
22,906
+6,993
+44% +$54.7K 0.01% 868
2025
Q1
$117K Sell
15,913
-4,608
-22% -$35.4K 0.01% 939
2024
Q4
$175K Sell
20,521
-1,836
-8% -$17.9K 0.01% 1030
2024
Q3
$195K Sell
22,357
-20,825
-48% -$172K 0.01% 1059
2024
Q2
$295K Buy
43,182
+31,314
+264% +$193K 0.01% 726
2024
Q1
$108K Buy
+11,868
New +$84.2K ﹤0.01% 1124
2023
Q4
Sell
-20,827
Closed -$65.4K 1149
2023
Q3
$65.4K Buy
20,827
+10,099
+94% +$41.3K ﹤0.01% 954
2023
Q2
$55.4K Buy
+10,728
New +$63.8K ﹤0.01% 1058

Other funds holding OCUL